Quanterix (QTRX) Profit After Tax (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.12% |
| Dec 31, 2025 | 31.03% |
| Sep 30, 2025 | -11.67% |
| Jun 30, 2025 | -46.38% |
| Mar 31, 2025 | -76.80% |
| Dec 31, 2024 | -38.84% |
| Sep 30, 2024 | -13.08% |
| Jun 30, 2024 | 33.83% |
| Mar 31, 2024 | -26.67% |
| Dec 31, 2023 | -31.22% |
| Sep 30, 2023 | -20.99% |
| Jun 30, 2023 | 23.69% |
| Mar 31, 2023 | 60.03% |
| Dec 31, 2022 | 50.21% |
| Sep 30, 2022 | -35.84% |
| Jun 30, 2022 | -50.15% |
| Mar 31, 2022 | -0.46% |
| Dec 31, 2021 | -13.90% |
| Sep 30, 2021 | -31.64% |
| Jun 30, 2021 | -17.75% |
| Mar 31, 2021 | -2.88% |
| Dec 31, 2020 | -545.80% |
| Sep 30, 2020 | 117.91% |
| Jun 30, 2020 | -5.96% |
| Mar 31, 2020 | -5.95% |
| Dec 31, 2019 | -11.02% |
| Sep 30, 2019 | 6.56% |
| Jun 30, 2019 | -12.31% |
| Mar 31, 2019 | -0.76% |
| Dec 31, 2018 | -21.90% |
| Sep 30, 2018 | -4.28% |
| Jun 30, 2018 | -1.96% |
| Mar 31, 2018 | 2.44% |
| Dec 31, 2017 | -11.61% |
| Sep 30, 2017 | 0.27% |
| Jun 30, 2017 | -3.77% |